Crystalline aggregation in vitro: Interaction between urinary macromolecules and the micromolecular environment

Acta Biomedica de l'Ateneo Parmense

Volumn 73, Issue 1-2, 2002, Pages 11-26

  Guerra, Angela ^a   Allegri, Franca ^a   Meschi, Tiziana ^a   Novarini, Almerico ^a   Schianchi, Tania ^a   Borghi, Loris ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Calcium oxalate stones; Crystal aggregation; Macromolecules; Oxalate tolerance; Urinary stone risk factors

Indexed keywords

CALCIUM OXALATE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CRYSTALLIZATION; FILTER; HUMAN; IN VITRO STUDY; LABORATORY TEST; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NEPHROLITHIASIS; RISK ASSESSMENT; RISK FACTOR; URINE FLOW RATE;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM OXALATE; CRYSTALLIZATION; HUMANS; MACROMOLECULAR SUBSTANCES; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; RECURRENCE; URINARY CALCULI; URINE;

EID: 0036347090     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls
2. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers
3. Calcium crystalluria in recurrent renal stone formers
4. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers
5. Crystal agglomeration is a major element in calcium oxalate urinary stone formation
6. Crystallization properties in urine from calcium oxalate stone formers
7. Reduced crystallization inhibition by urine from men with nephrolithiasis
8. Calcium stones: Some physical and clinical aspects
9. The effect of macromolecules on the crystallization of calcium oxalate in human urine
10. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine
11. Studies on the role of urinary macromolecules in urolithiasis: Review of methodologies and a proposal for a standard reference crystallization system
12. Changes in urine macromolecular composition during processing
13. Competition between the known inhibitors and promoters of calcium oxalate crystallization in urine
14. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine
15. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins
16. Effects of urinary macromolecules on the crystallization of calcium oxalate
17. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine
18. Interactions between stone-forming calcific crystals and macromolecules
19. Measurement of metastability, growth and aggregation of calcium oxalate in native urine
20. Nucleation, growth, and aggregation of stone-forming crystals
21. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay
22. Oxalate crystalluria
23. Uromucoids and urinary stone formation
24. Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine?
25. Tamm-Horsfall glycoprotein-inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
26. Tamm-Horsfall glycoprotein and calcium nephrolithiasis
27. Factors determining the aggregation of urinary mucoprotein
28. The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein
29. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation
30. Small-Molecular-Weight inhibitors
31. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium
32. Isolation of calcium oxalate growth inhibitor from rat kidney and urine
33. Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors